新興鑄管(000778.SZ):“飲用水安全保障技術體系創建與應用”項目榮獲國家科技進步一等獎
格隆匯6月23日丨新興鑄管(000778.SZ)在投資者關係表示,在球墨鑄鐵管新材料、產品、工藝、智能化等開展自主研發,具備人才、專利、標準、工業數據等多方面優勢。科技創新體系建設逐步完善,全面修訂科技創新管理制度,打通基層創新的激勵通道,構建了具有自身特色的“1+4+N+ASI”全員科技創新體系。“飲用水安全保障技術體系創建與應用”項目榮獲國家科技進步一等獎。標準引領保障作用進一步凸顯,主持參與標準制修訂12項,其中主持發佈國際標準1項,參與編制國際標準2項,實現標準行業引領。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.